BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1983546)

  • 1. [Partial resection of primary liver cell cancer].
    Kremer B; Henne-Bruns D; Jordan A; Witte G
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():153-6. PubMed ID: 1983546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and surgery of primary hepatic cancer with portal vengus tumor thrombosis].
    Liu YB; Jian ZX; Ou JR; Liu ZX
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):436-8. PubMed ID: 15854368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
    Li JQ; Zhang YQ; Zhang WZ
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
    Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
    Hasse F; Mehring UM; Castaneda F; Jäger H; Mathias KD; Löhlein D
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():208-10. PubMed ID: 9101833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver resection after transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma and curative effect analysis].
    Fan J; Yu Y; Wu Z
    Zhonghua Wai Ke Za Zhi; 1997 Dec; 35(12):710-2. PubMed ID: 10677986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined hepatic artery chemoembolization and portal vein chemotherapy after radical resection of hepatocellular carcinoma to prevent recurrence].
    Li H; Ou Q; Chen J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):61-3. PubMed ID: 11776603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.
    Ochiai T; Sonoyama T; Hironaka T; Yamagishi H
    Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z; Ren Z; Xia J
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
    Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
    Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year survival after monotherapy for hepatocellular carcinoma in the setting of cirrhosis.
    Fouzas I; Sotiropoulos GC; Sgourakis G; Drühe N; Wohlschlaeger J; Molmenti EP; Broelsch CE; Lang H
    Transplant Proc; 2008 Nov; 40(9):3204-5. PubMed ID: 19010235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.